Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Terveystalo Plc: The Finnish Competition and Consumer Authority applies for an extension for investigating the transaction between Terveystalo and Attendo | ||
By: Nasdaq / GlobeNewswire - 05 Oct 2018 | Back to overview list |
|
Terveystalo Plc Stock Exchange release 5 October 2018 at 09:00 a.m EEST Terveystalo Plc ("Terveystalo") has on 17 May 2018 signed an agreement to acquire the Finnish healthcare operations of Attendo AB (publ) ("Attendo") (the "Transaction"). The Transaction was announced in Terveystalo's stock exchange release of 17 May 2018. The completion of the Transaction is subject to the approval by the competition authority. The Finnish Competition and Consumer Authority (the "FCCA") investigations concerning the Transaction between Terveystalo and Attendo's Finnish healthcare business are still pending and the FCCA has today applied for an extension to the investigations from the Finnish Market Court until 14 December 2018. Should the Finnish Market Court grant the applied extension and the FCCA approve the Transaction during such extension, the completion of the Transaction is still expected to take place within the previously estimated timetable for the completion of the Transaction at the end of 2018, irrespective of the possible extension period. Terveystalo Plc Further enquiries Distribution: Terveystalo in brief Terveystalo is a listed company on the Helsinki Stock Exchange. Terveystalo is the largest healthcare service company in Finland with net sales and network. The company offers versatile primary and secondary health care services for corporate and private customers and the public sector. The nationwide network covers 180 locations across Finland, complemented by 24/7 digital services. |
||
|
||
Copyright 2018 Nasdaq / GlobeNewswire | Back to overview list |